1.
Systolic pressure is all that matters
by Williams, Bryan, Prof
The Lancet (British edition), 2008, Vol.371 (9631), p.2219-2221
2.
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
by Weber, Michael A, Prof
The Lancet (British edition), 2009, Vol.374 (9699), p.1423-1431
3.
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
by Dahlöf, Björn
The Lancet (British edition), 2002-03-23, Vol.359 (9311), p.995-1003
4.
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenol...
by Lindholm, Lars H
The Lancet (British edition), 2002-03-23, Vol.359 (9311), p.1004-1010
5.
Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (C...
by Hansson, Lennart
The Lancet (British edition), 1999, Vol.353 (9153), p.611-616
6.
Blood-pressure drugs and cancer: much ado about nothing?
by Lindholm, Lars H
The lancet oncology, 2011, Vol.12 (1), p.6-8
7.
Blood-pressure-related disease is a global health priority
by MacMahon, Stephen
American journal of hypertension, 2008, Vol.371 (9623), p.1480-1482
8.
Divergent Results Using Clinic and Ambulatory Blood Pressures: Report of a Darusentan-Resistant Hypertension Trial
by Bakris, George L
Hypertension (Dallas, Tex. 1979), 2010-11, Vol.56 (5), p.824-830
9.
Effect of losartan on sudden cardiac death in people with diabetes: data from the LIFE study
by Lindholm, Lars H
The Lancet (British edition), 2003-08-23, Vol.362 (9384), p.619-620
10.
Greater Regression of Electrocardiographic Left Ventricular Hypertrophy During Hydrochlorothiazide Therapy in Hypertensive Patients
by Okin, Peter M.
American journal of hypertension, 2010-07, Vol.23 (7), p.786-793
11.
Relation between drug treatment and cancer in hypertensives in the Swedish Trial in Old Patients with hypertension 2: a 5-year, prospective, randomised, controlled trial
by LINDHOLM, Lars H
The Lancet (British edition), 2001, Vol.358 (9281), p.539-544
12.
Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study
by Ibsen, Hans
Hypertension (Dallas, Tex. 1979), 2005-02, Vol.45 (2), p.198-202
13.
Valsartan treatment of hypertension—does VALUE add value?
by Lindholm, Lars H
The Lancet (British edition), 2004-06-19, Vol.363 (9426), p.2010-2011
14.
Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) s...
by Hansson, Lennart
The Lancet (British edition), 2000, Vol.356 (9227), p.359-365
15.
Combination of the Electrocardiographic Strain Pattern and Albuminuria for the Prediction of New-onset Heart Failure in Hypertensive Patients: The LIFE Study
by Okin, Peter M.
American journal of hypertension, 2008-03, Vol.21 (3), p.273-279
16.
Prognostic importance of hemoglobin in hypertensive patients with electrocardiographic left ventricular hypertrophy: The Losartan Intervention For End point reduction in hypertensi...
by Olsen, Michael Hecht, MD, PhD
The American heart journal, 2009, Vol.157 (1), p.177-184
17.
In-Treatment Resolution or Absence of Electrocardiographic Left Ventricular Hypertrophy Is Associated With Decreased Incidence of New-Onset Diabetes Mellitus in Hypertensive Patien...
by Okin, Peter M
Hypertension (Dallas, Tex. 1979), 2007-11, Vol.50 (5), p.984-990
18.
Hospitalizations for New Heart Failure Among Subjects With Diabetes Mellitus in the RENAAL and LIFE Studies
by Carr, Albert A
The American journal of cardiology, 2005, Vol.96 (11), p.1530-1536
19.
Stroke Reduction in Hypertensive Adults With Cardiac Hypertrophy Randomized to Losartan Versus Atenolol: The Losartan Intervention For Endpoint Reduction in Hypertension Study
by Kizer, Jorge R
Hypertension (Dallas, Tex. 1979), 2005-01, Vol.45 (1), p.46-52
20.
Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis
by Lindholm, Lars Hjalmar
The Lancet (British edition), 2005, Vol.366 (9496), p.1545-1553
Filter electronic articles 29 Hits
Remove Filters
- Subjects
- Humans (29)
- Hypertension - Drug Therapy
- Science & Technology (28)
- more ...